[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351488-105":59,"doc-detail-351488-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","artificial-intelligence-and-prostatebreast-cancer-biology-recent-advances-in-treatments-and-perspectives-a-comprehensive-review","Artificial Intelligence and Prostate–Breast Cancer Biology - Recent Advances in Treatments and Perspectives - A Comprehensive Review","","Therapeutic limitations in conventional cancer care are driving development of new nanodrugs, while both prostate cancer and breast cancer remain major global burdens with high incidence and mortality. This narrative review synthesizes recent advances in cancer biology, imaging technologies, and therapeutic approaches, highlighting genomic landscape and oncogenesis in localized and metastatic disease. It evaluates how nanomedicine and artificial intelligence can address accessibility, drug resistance, and side effects. Conclusions emphasize reduced adverse effects, improved efficacy, and potential synergy with conventional therapies.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/artificial-intelligence-and-prostatebreast-cancer-biology-recent-advances-in-treatments-and-perspectives-a-comprehensive-review/351488/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/artificial-intelligence-and-prostatebreast-cancer-biology-recent-advances-in-treatments-and-perspectives-a-comprehensive-review/351488.png","ImageObject",300,407,{"name":92,"@type":93},"Angel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What challenges in current cancer treatments does the review address?","Question",{"text":112,"@type":113},"It highlights therapeutic challenges including limited accessibility, drug resistance, and side effects across current treatment strategies.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does nanomedicine contribute to prostate and breast cancer therapy?",{"text":117,"@type":113},"The review explains that nanotechnologies can reduce adverse effects, enhance treatment efficacy, and improve patient outcomes, especially when combined with conventional therapies.",{"name":119,"@type":110,"acceptedAnswer":120},"What role do artificial intelligence models play in the proposed approaches?",{"text":121,"@type":113},"It describes AI models supporting imaging, therapy, and drug delivery, offering solutions to the accessibility, resistance, and side-effect limitations discussed in the review.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351488,1790467829,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},687207412472,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Health Science Reports   \nNARRATIVE REVIEW   \nArtificial Intelligence and Prostate–Breast  \nCancer Biology: Recent Advances in Treatments and Perspectives—A Comprehensive Review  \nRussell B. O. Ouma  | Silas M. Ngari  | Joshua K. Kibet  Department of Chemistry, Egerton University, Njoro, Kenya  \nCorrespondence: Joshua K. Kibet ([jkibet@egerton.ac.ke](jkibet@egerton.ac.ke))  \nReceived: 24 June 2025 | Revised: 15 December 2025 | Accepted: 11 March 2026  \nKeywords: breast cancer | mortality rates | nanomedicine | oncogenesis | Prostate cancer | targeted therapies  \nABSTRACT  \nBackground and Aims: The therapeutic limitations of conventional cancer treatment currently deployed are driving the development and creation of new nano‐drugs. Prostate cancer (PCa) is a prevalent clinical problem in older men with a significant global incidence, with 1.5 million cases reported in 2022. Breast cancer (BC) is also a considerable health burden among women worldwide, with reports showing over 67,000 deaths in 2022. Generally, across the world, cancer has posed significant health burden due to limited access to treatment options, high incidence rates, and mortality rates occasioned by lifestyle and genetic factors. This review explores the potential of nanomedicine and artificial intelligence (AI) to overcome these limitations and improve patient outcomes, and provides an insightful overview of the available cancer treatment options, such as radiation therapy, surgery, hormone therapy, chemotherapy, and targeted therapies, focusing on PCa and BC. Methods: A comprehensive synthesis of recent literature has been conducted, focusing on enormous advances that have been made to understand the biology of various cancers, imaging technologies, and therapeutic approaches. Subsequently, cancer management has evolved rapidly, focusing on the genomic landscape and oncogenesis of localized and metastatic cancers. Results: The current treatment strategies face therapeutic challenges related to accessibility issues, drug resistance, and side effects. The emergence of nanomedicine and artificial intelligence (AI) models in imaging, therapy, and drug delivery offers solutions related to these challenges. Nanomedicine is a growing research hotspot with an increased number of publications with keywords such as “prodrug,”“cancer nanomedicine,”“cancer immunotherapy,” “artificial intelligence,” and “targeted nanomedicine”.  \nConclusions: The nanotechnologies utilized in cancer treatment reduce side effects, enhance treatment efficacy, and improve patient outcomes. Combining nanomedicine with conventional therapies holds promise in revolutionizing cancer treatment and addressing the clinical challenges of current therapies.  \n1 | Introduction  \nCancer is one of the most acute problems in biomedical science and clinical medicine, not only because of its burden globally but also because of the complexity of its biology and the perpetual development of resistance to therapeutic interventions [1, 2] . Present‐day genetic disease framing of cancer evolved  \nover decades of discovery [3] . By the mid‐20th century, cancer was seen as an uncontrolled growth of cells, and histopathological classification came into focus [4] . The discovery of tumour protein 53 (TP53), retinoblastoma (RB1), and myelocytomatosis (MYC) in the 1970s and 1980s offered a mechanistic understanding of how genetic changes contribute to tumour development, shifting pathology towards molecular  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2026 The Author(s) . Health Science Reports published by Wiley Periodicals LLC.  \nHealth Science Reports, 2026; 9:e72117 1 of 16  \n[https://doi.org/10.1002/hsr2.72117](https://doi.org/10.1002/hsr2.72117)  \ncausation [5] . Prostate‐specific antigen (PSA) testing, introduced in the late 1980s, transformed prost","cbCaig6J8yTzLGn5","https://ap.wps.com/l/cbCaig6J8yTzLGn5","pdf",3007254,16,"English","# Introduction\n## Cancer genomics, resistance, and molecular markers\n# Diagnostic and screening approaches\n## PSA and biomarker-based detection\n## Breast biopsy and non-invasive biomarker testing\n# Treatment challenges and emerging solutions\n## Limitations of surgery, chemotherapy, and radiation\n## Targeted therapies and immunotherapy\n## Role of nanomedicine and AI","[{\"question\":\"What challenges in current cancer treatments does the review address?\",\"answer\":\"It highlights therapeutic challenges including limited accessibility, drug resistance, and side effects across current treatment strategies.\"},{\"question\":\"How does nanomedicine contribute to prostate and breast cancer therapy?\",\"answer\":\"The review explains that nanotechnologies can reduce adverse effects, enhance treatment efficacy, and improve patient outcomes, especially when combined with conventional therapies.\"},{\"question\":\"What role do artificial intelligence models play in the proposed approaches?\",\"answer\":\"It describes AI models supporting imaging, therapy, and drug delivery, offering solutions to the accessibility, resistance, and side-effect limitations discussed in the review.\"}]","Artificial Intelligence and Prostate–Breast Cancer Biology - Recent Advances in Treatments and Perspectives - A Comprehensive Review | PDF",1790094378,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e124955723534859b69d62c405ab568a.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3b3f404d1b8678e27511d93cbe872d08.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bd29cc5a1c5126750755616f50ef1c19.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1750a3591ccf9a75d43be8f3c5ca9994.webp",980,1287]